A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency
Abstract
Glutamate secretion at excitatory synapses is tightly regulated to allow for the precise tuning of synaptic strength. Vesicular Glutamate Transporters (VGLUT) accumulate glutamate into synaptic vesicles (SV) and thereby regulate quantal size. Further, the number of release sites and the release probability of SVs maybe regulated by the organization of active zone proteins and SV clusters. In the present work, we uncover a mechanism mediating an increased SV clustering through the interaction of VGLUT1 second proline-rich domain, endophilinA1 and intersectin1. This strengthening of SV clusters results in a combined reduction of axonal SV super-pool size and miniature excitatory events frequency. Our findings support a model in which clustered vesicles are held together through multiple weak interactions between Src homology 3 and proline-rich domains of synaptic proteins. In mammals, VGLUT1 gained a proline-rich sequence that recruits endophilinA1 and turns the transporter into a regulator of SV organization and spontaneous release.
Data availability
Raw measures and intermediate data processing of images and electrophysiology traces are submited in source files appended to this submission.Source images and electrophysiology traces reported in this study are fully available upon request to the corresponding author (Etienne Herzog - https://orcid.org/0000-0002-0058-6959).
Article and author information
Author details
Funding
Agence Nationale de la Recherche (ANR-12-JSV4-0005-01 VGLUT-IQ)
- Etienne Herzog
Agence Nationale de la Recherche (ANR-10-LABX-43 BRAIN)
- Yann Humeau
- Etienne Herzog
Agence Nationale de la Recherche (ANR-10-IDEX-03-02 PEPS SV-PIT)
- Etienne Herzog
Agence Nationale de la Recherche (PSYVGLUT 09-MNPS-033)
- Salah El Mestikawy
Agence Nationale de la Recherche (ANR-10-INBS-04)
- Fabrice P Cordelières
European Commission (Erasmus-Mundus European Neuroscience Campus Program)
- Xiao Min Zhang
- Etienne Herzog
Fondation pour la Recherche Médicale (FDT20120925288)
- Kätlin Silm
Fondation pour la Recherche Médicale (ING20150532192)
- Maria Florencia Angelo
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: The experimental design and all procedures were in accordance with the European guide for the care and use of laboratory animals, approved by the ethics committee of Bordeaux Universities (CE50), and registered with the french ministry for research under the APAFIS n{degree sign}1692. Every effort was made to minimize the number of animals used and their suffering.
Reviewing Editor
- Reinhard Jahn, Max Planck Institute for Biophysical Chemistry, Germany
Publication history
- Received: July 22, 2019
- Accepted: October 27, 2019
- Accepted Manuscript published: October 30, 2019 (version 1)
- Version of Record published: November 18, 2019 (version 2)
Copyright
© 2019, Zhang et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,140
- Page views
-
- 366
- Downloads
-
- 9
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Immunology and Inflammation
Tristetraprolin (TTP) is a critical negative immune regulator. It binds AU-rich elements in the untranslated-regions of many mRNAs encoding pro-inflammatory mediators, thereby accelerating their decay. A key but poorly understood mechanism of TTP regulation is its timely proteolytic removal: TTP is degraded by the proteasome through yet unidentified phosphorylation-controlled drivers. In this study, we set out to identify factors controlling TTP stability. Cellular assays showed that TTP is strongly lysine-ubiquitinated, which is required for its turnover. A genetic screen identified the ubiquitin E3 ligase HUWE1 as a strong regulator of TTP proteasomal degradation, which we found to control TTP stability indirectly by regulating its phosphorylation. Pharmacological assessment of multiple kinases revealed that HUWE1-regulated TTP phosphorylation and stability was independent of the previously characterized effects of MAPK-mediated S52/S178 phosphorylation. HUWE1 function was dependent on phosphatase and E3 ligase binding sites identified in the TTP C-terminus. Our findings indicate that while phosphorylation of S52/S178 is critical for TTP stabilization at earlier times after pro-inflammatory stimulation, phosphorylation of the TTP C-terminus controls its stability at later stages.
-
- Cell Biology
We show that TANGO2 in mammalian cells localizes predominantly to mitochondria and partially at mitochondria sites juxtaposed to lipid droplets (LDs) and the endoplasmic reticulum. HepG2 cells and fibroblasts of patients lacking TANGO2 exhibit enlarged LDs. Quantitative lipidomics revealed a marked increase in lysophosphatidic acid (LPA) and a concomitant decrease in its biosynthetic precursor phosphatidic acid (PA). These changes were exacerbated in nutrient-starved cells. Based on our data, we suggest that TANGO2 function is linked to acyl-CoA metabolism, which is necessary for the acylation of LPA to generate PA. The defect in acyl-CoA availability impacts the metabolism of many other fatty acids, generates high levels of reactive oxygen (ROS), and promotes lipid peroxidation. We suggest that the increased size of LDs is a combination of enrichment in peroxidized lipids and a defect in their catabolism. Our findings help explain the physiological consequence of mutations in TANGO2 that induce acute metabolic crises, including rhabdomyolysis, cardiomyopathy, and cardiac arrhythmias, often leading to fatality upon starvation and stress.